Tesamorelin

For laboratory research use only. Not for human consumption.

Tesamorelin is a synthetic peptide that functions as an analogue of growth hormone–releasing hormone (GHRH). By stimulating GHRH receptors in the pituitary, it promotes pulsatile secretion of growth hormone and downstream IGF-1 pathway activity. In research settings, tesamorelin is used to study growth hormone axis regulation, including its effects on body composition, lipid metabolism, and endocrine signalling, as well as broader investigations into age- and condition-related changes in GH/IGF-1 dynamics.

It is also indicated for the reduction of excess abdominal fat in HIV-infected patients with lipodystrophy. Lipodystrophy is a metabolic condition characterized by insulin resistance, fat redistribution, and hyperlipidemia associated with antiretroviral therapy for HIV infection.

National Center for Biotechnology Information. “PubChem Compound Summary for CID 16137828, Tesamorelin” PubChem, https://pubchem.ncbi.nlm.nih.gov/compound/Tesamorelin.